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ORIGINAL ARTICLE

Exome sequencing of 85 Williams–Beuren syndrome cases rules
out coding variation as a major contributor to remaining
variance in social behavior
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Abstract
Background: Large, multigenic deletions at chromosome 7q11.23 result in a

National Heart Lung and Blood Institute,
National Institutes of Health, Bethesda,
Maryland

highly penetrant constellation of physical and behavioral symptoms known as Williams–Beuren syndrome (WS). Of particular interest is the unusual social‐cogni-
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tive profile evidenced by deficits in social cognition and communication
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reminiscent of autism spectrum disorders (ASD) that are juxtaposed with normal
or even relatively enhanced social motivation. Interestingly, duplications in the
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same region also result in ASD‐like phenotypes as well as social phobias. Thus,
the region clearly regulates human social motivation and behavior, yet the relevant
gene(s) have not been definitively identified.
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Method: Here, we deeply phenotyped 85 individuals with WS and used exome
sequencing to analyze common and rare variation for association with the remaining variance in social behavior as assessed by the Social Responsiveness Scale.
Results: We replicated the previously reported unusual juxtaposition of behavioral
symptoms in this new patient collection, but we did not find any new alleles of large
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effect in the targeted analysis of the remaining copy of genes in the Williams syndrome
critical region. However, we report on two nominally significant SNPs in two genes that
have been implicated in the cognitive and social phenotypes of Williams syndrome,
BAZ1B and GTF2IRD1. Secondary discovery driven explorations focusing on known
ASD genes and an exome wide scan do not highlight any variants of a large effect.
Conclusions: Whole exome sequencing of 85 individuals with WS did not support
the hypothesis that there are variants of large effect within the remaining Williams syndrome critical region that contribute to the social phenotype. This deeply phenotyped
and genotyped patient cohort with a defined mutation provides the opportunity for similar analyses focusing on noncoding variation and/or other phenotypic domains.
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autism spectrum disorder, exome variation, social responsiveness scale, Williams–Beuren syndrome
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| INTRODUCTION

Williams–Beuren syndrome (WS) (OMIM #194050) is a
neurodevelopmental disorder caused by a 1.5 to 1.8 Mbp
deletion on chromosome 7q11.23. The deletion causes a
constellation of symptoms that include cardiovascular
pathology, craniofacial dysmorphology, and a unique cognitive and personality profile (Järvinen, Korenberg, & Bellugi, 2013; Mervis et al., 2000; Williams, Barratt‐Boyes, &
Lowe, 1961). The well‐defined genetic lesion that causes
WS is an opportunity to assess genotype–phenotype correlations. To date, only the cardiovascular phenotype has
been convincingly linked to the haploinsufficiency of a single gene—the ELN gene (Ewart et al., 1993; Li et al.,
1997). Studying rare events that result in atypical deletions
sparing different genes in the Williams syndrome critical
region (WSCR), as well as single gene knock out studies
in mouse models, have suggested that GTF2IRD1 and
BAZ1B play a role in the craniofacial abnormalities (Ashe
et al., 2008; Tassabehji et al., 2005). Likewise, the genes
STX1A, LIMK1, CYLN2, BAZ1B, GTF2IRD1, and GTF2I
(Dai et al., 2009; Fujiwara, Sanada, Kofuji, & Akagawa,
2016; Gao et al., 2010; van Hagen et al., 2007; Hoogenraad et al., 2002; Lalli et al., 2016; Meng et al., 2002;
Morris et al., 2003; Sakurai et al., 2011) have been implicated in the cognitive and behavioral phenotypes.
Understanding contributions to social phenotypes in particular for WS may define genes that regulate human social
behavior, providing insight not only into WS, but also in
other disorders as well as possible modifiers of social
behavior in the general population. Deleting one copy of
the genes in the WSCR produces the personality profile
observed in WS, which consists of prosocial behaviors
such as gregariousness, empathy, retained expressive language skills, and low levels of social anxiety, in spite of
high anxiety in other domains (Doyle, Bellugi, Korenberg,
& Graham, 2004; Gosch & Pankau, 1997; Järvinen et al.,
2013; Reilly, Klima, & Bellugi, 1990; Tager‐Flusberg &
Sullivan, 2000). Despite the high social motivation of individuals with WS, they exhibit deficits in social cognition
and communication (Klein‐Tasman, Li‐Barber, & Magargee, 2010; Klein‐Tasman, Mervis, Lord, & Phillips, 2007;
Klein‐Tasman, Phillips, Lord, Mervis, & Gallo, 2009). The
Williams syndrome critical region duplication, 7q11.23
duplication syndrome (Dup7) (OMIM#609757), conversely,
is characterized by diametric social behaviors to those seen
in WS, including separation anxiety, poor eye contact, and
language impairment, as well as overlapping phenotypes
such as restricted and repetitive behavior and poor social
communication (Klein‐Tasman & Mervis, 2018). It has also
been shown that the prevalence of ASD in WS and Dup7
is higher than in the general population and the male sex
bias for ASD diagnosis is present among individuals with
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Dup7 (Klein‐Tasman & Mervis, 2018; Richards, Jones,
Groves, Moss, & Oliver, 2015). The similarities and differences in the social communication domains of WS and
ASD have been described, and suggest that while both disorders show deficits in social communication, the WS
group was not as impaired as the ASD group (Klein‐Tasman et al., 2007, 2009). Unlike ASD, there is no sex bias
in the frequency of WS and severity of social and cognitive
phenotypes are similar across both sexes (Brawn & Porter,
2014; Dykens, 2003).
As in many diseases of haploinsufficiency, within WS
there remains considerable variability in expressivity of the
phenotypes, despite the very homogeneous genetic cause. It
is thought that both genetic background and the environment introduce variation in the expression of a phenotype.
The fact that individuals with WS are hemizygous for 26–
28 genes has led to the assertion that variation in the
remaining allele could contribute to the severity of symptoms in WS (Delio et al., 2013; Merla, Brunetti‐Pierri,
Micale, & Fusco, 2010). The presence of only one copy of
genes in the WSCR could unmask the effects of recessive
alleles in the region that are more difficult to detect in a
diploid setting. Indeed, this logic has been applied to investigate the variability in the cardiovascular phenotype. Delio
et al., 2013 sequenced the exons that make up the ELN
gene in a sample of 55 individuals with WS, but found no
clear link between severity of phenotype and remaining
genetic variation. However, no similar studies have investigated the social profile of WS, in spite of the fact that there
is some evidence that common variation in the region can
influence social behavior in the general population. For
example, variation in the GTF2I gene has been associated
with the WS cognitive profile, autism, oxytocin reactivity,
amygdala activity, and social anxiety (Crespi & Hurd,
2014; Jabbi et al., 2015; Procyshyn, Spence, Read, Watson,
& Crespi, 2017). Furthermore, genes outside of the WSCR
are also likely to affect aspects of social behavior. In particular genes that are associated with ASD have a profound
effect on social interaction and could harbor variants that
modify the phenotype of individuals with WS.
Here, we employ whole exome sequencing to understand how genetic variation within the WSCR, and other
protein coding genes, impacts the severity of the WS social
phenotype. We generate a rich catalog of genetic variants
identified from 85 individuals with the typical WS deletions; each individual has also been assessed with the
Social Responsiveness Scale‐2 (SRS) questionnaire, a
quantitative measure of reciprocal social behavior. The
SRS was first developed to quantify autistic traits in both
the general and clinical populations (Constantino & Todd,
2003; Moreno‐De‐Luca et al., 2015). SRS scores have also
been used to describe different aspects of the social phenotype in WS (Klein‐Tasman et al., 2010). We then employ a
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three‐tiered approach to screen for the existence of alleles
that contribute to SRS scores in the context of a potentially
sensitizing WSCR deletion, ordering the analyses to conserve statistical power. First, we describe the genetic variants observed in the remaining WSCR and test if they can
explain the variance in the SRS scores. We find little evidence that these common or rare variants in the region are
associated with SRS scores. Next, we go beyond the
WSCR and test variants in 71 genes known to be associated with ASD (Sanders et al., 2015), reasoning variation
that contributes to autistic features in non‐WS children may
modify autistic features in the WS cohort as well. Finally,
we test variants throughout the whole exome. We find no
genetic variants of sufficient effect size to support the
hypothesis that they contribute to the social phenotype in
this sample of individuals with WS. However, we have
more thoroughly described the variation in the WSCR
region as it relates to social behavior and provide the largest genetic dataset to date of individuals with typical WS
deletions for future analyses of other phenotypic domains.

2
2.1

| MATERIALS AND METHODS
| Ethical compliance and samples

This study was conducted with approval of the IRBs at
Washington University School of Medicine and the
National Institutes of Health. Consent was obtained prior to
inclusion in the study. Once enrolled, participants provided
a DNA sample by blood or saliva and their care‐givers
filled out health related questionnaires. The 85 individuals
that make up our sample have ages that range from 2.5 to
65.5 years with a mean of 16.1 years. Caregivers provided
a self‐reported ethnicity. The majority of the sample was
reported as white (77 individuals). There are two individuals that are African American, three Chinese, and three
others.

2.2
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| Confirmation of diagnosis

WS diagnosis and typical deletion size was confirmed using
either chromosomal microarray or quantitative PCR. In some
cases, clinical microarray results were derived from the medical record. Array type varied by individual. For the remaining individuals, some received a research array (Cytoscan
HD, Applied Biosystems) with analysis using the accompanying ChAS software. Others underwent deletion size assessment using quantitative PCR for genes within and outside of
the Williams region using Taqman copy number probes
(Thermo‐Fisher, AUTS2: Hs04984177_cn, CALN1:
Hs04946916_cn, FZD9: Hs03649975_cn, CLIP2: Hs00899
301_cn, HIP1: Hs00052426_cn, POM121C: Hs075298
20_cn). Copy number analysis was done according to the
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manufacturer's instructions and output data analyzed using
their Copy Caller software. All individuals were confirmed
to have deletions that included the WSCR genes ELN, FZD9
and CLIP2, but did not include genes external to the typical
deletion such as CALN, AUTS2, POM121C or HIP1 (data
not shown).

2.3

| Social responsiveness scale

The social responsiveness scale‐2 (SRS) is a 65‐item questionnaire that measures aspects of social interaction that
make up the core symptoms of autism spectrum disorders.
The output is a total raw score as well as a T‐score that is
adjusted for sex, age, and the relationship of the reporter to
the proband. The total score is made up of the scores of five
subcategories that are impaired in ASDs: social awareness
(AWR), social cognition (COG), social motivation (MOT),
social communication (COM), and behaviors typical of autism such as restricted interests and repetitive behaviors
(RRB). The response to each question ranges from 1 (not
true) to 4 (almost always true). The T‐scores are binned into
four groups: normal <59, mild between 60 and 65, moderate
between 66 and 75, and severe >76. For this study, the age‐
specific (preschool, school age, or adult) SRS‐2 was completed by the participant's caregiver and analyzed as a T‐
score that is adjusted for sex, age, and the relationship of the
reporter. We provide values from the general population that
have been previously reported for comparison (Constantino
& Todd, 2003; Constantino et al., 2003).

2.4

| Sequencing and variant calling

Whole exome sequencing and alignment was performed at
Washington University in St. Louis by the McDonnell
Genome Institute on 85 DNA samples from individuals
with WS. Exomes were captured using Nimblegen SeqCap
EZ Choice HGSC Library version 2.1, which targets 45.1
Mbp covering 23,585 genes and 189,028 nonoverlapping
exons. Exomes were aligned to the GRCh37‐lite genome
using bwa –mem v0.7.10 (Li & Durbin, 2009) default settings, samtools v0.1.19 (Li et al., 2009) was used to assign
mate pairings, sort, and index the bam files. Duplicates
were marked using Picard MarkDuplicates v1.113.
Variant calling was done following GATK best practices on the aligned exomes (DePristo et al., 2011). Briefly,
using GATK v3.6.0 indels were realigned and the base
quality scores recalibrated. Variants were initially called
per sample using the haplotype caller tool, followed by
jointly calling variants. To improve variant calls, we recalibrated variants and used a truth sensitivity tranche of 97
for SNPs, and a truth sensitivity tranche of 94 for indels.
These thresholds were chosen to maximize the number of
known and novel variants while still being stringent
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enough to limit the number of false positive variant calls.
To further filter the variants we used the VariantFiltration
tool to filter variant sites that had lower than a 10× average
coverage or an inbreeding coefficient < −0.20 to remove
sites with excess heterozygosity. Genotype calls were filtered and considered to be missing if they had a genotype
quality score of <20, which refers to a 99% probability that
the call is correct. Finally, using vcftools v0.1.14 (Danecek
et al., 2011), we removed sites that had a genotype missing
rate of >10%, as well as sites that no longer showed any
variation. This produced a call set of 202,820 variant sites.
The final call set has a Ti/Tv ratio of 2.76 and a dbSNP
rate of 88.5%. These metrics are consistent with quality
variant calls and a low false positive rate.

2.5

| Variant annotation

The variant call set was split into three groups using
vcftools: (1) variants in the Williams syndrome critical
region
(WSCR)
defined
by
hg19
coordinates
chr7:72,395,660–74,267,841 (2) variants located in 71
genes associated with ASD (Sanders et al., 2015), and (3)
the remaining nonoverlapping variants. All sets include
exonic variants as well as variants located in introns that
are pulled down by the capture reagents. Bcftools v1.2 (Li
et al., 2009) was used to split multiallelic sites into separate
lines for each allele and left normalized so positions would
be compatible with ANNOVAR annotation files version
2016‐02‐01 (Wang, Li, & Hakonarson, 2010). The ANNOVAR table_annovar.pl function was used to annotate all
three variant call sets with the RefSeq gene annotation,
variant consequence, ExAC allele frequency (Lek et al.,
2016), sample specific allele frequency, dbsnp147 name,
clinical significance assessed by ClinVar (Landrum et al.,
2016). Missense variants were also annotated with measures of deleteriousness compiled in dbNSFPv3.3a (Liu,
Wu, Li, & Boerwinkle, 2016). We highlight the CADD
PHRED score and MetaLR as two measures of variant
deleteriousness. CADD scores are defined at each base in
the genome and for every possible single‐nucleotide change
(Kircher et al., 2014). CADD scores compare 65 annotations, including functional data as well as conservation
scores, between fixed human derived alleles and simulated
variants. Deleterious variants should be depleted in the
observed fixed alleles and not in the simulated variants.
CADD PHRED scores represent the relative rank of a
CADD score compared to all other possible allele CADD
scores; a CADD score of 10 means this allele is ranked as
the top 10% of all possible CADD scores. Larger CADD
PHRED score indicates an increased predication of deleteriousness. MetaLR uses logistic regression to incorporate
information from nine other variant annotations that
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consider function as well as conservation (Dong et al.,
2015). The model was trained on true deleterious variants
and true neutral variants described in the Uniprot database.
The composite MetaLR score was found to have greater
predictive ability than any of the single scores that make
up MetaLR.

2.6

| Power analysis

We performed a power analysis to provide the limits of
genetic effects that we would be able to detect given our
cohort size. For future studies we also calculate the sample
sizes that would be needed to detect different magnitudes
of genetic effects. We used the Genetic Power Calculator
(Purcell, Cherny, & Sham, 2003). We calculated the predicted power of the current sample size n = 85 using a p‐
value threshold corresponding to the Bonferroni corrected
alpha for each set of analyses (WSCR 34 variants, alpha =
0.00147, ASD 381 variants, alpha = 0.000131, WEX
66620 variants, alpha = 7.5 × 10−7. Our main hypothesis
is variants on the remaining WSCR allele affect the social
phenotype; we wanted to calculate the sample sizes that
would be required to detect different size genetic effects in
the WSCR at different levels of power. We again used the
alpha threshold based on the 34 common variants we identified in the exons of the WSCR and report the sample size
required to achieve a specific power.

2.7

| Association analyses

2.7.1

| Common variant analysis

The variant call files were converted to plink binary bed
format using the GATK tool VariantToBinaryPed. We used
PLINK v1.9 (Purcell et al., 2007) –linear option to conduct
a quantitative trait association using the SRS T‐score as the
quantitative trait. Ancestry was controlled for by including
the first four principle components, determined by the –pca
function in PLINK, as covariates along with sex and age.
We used alleles that had a minor allele frequency (MAF)
of 0.05 or greater. We performed the association analyses
on the three separate groups of variants described in the
previous section. It should be noted that allele frequency in
the Williams syndrome critical region is inflated because of
the hemizygous state of the region in individuals with WS.
A MAF of 0.05 in this region corresponds to an allele
count of four. In all cases we report the effect size of a
variant under an additive model. Though the small sample
size of this study limits power, in an exploratory fashion
we also performed the same quantitative trait analysis on
each of the subscores of the SRS using variants in the
WSCR, ASD genes, and the whole exome.
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2.7.2

| SKAT‐O

SKAT‐O (Lee, Wu, & Lin, 2012)was implemented in the R
v3.1.3 environment. SKAT‐O fits a multiple linear regression of all SNPs located in a user provided region. The
framework in SKAT‐O allows for correlation between SNPs
in a region, where if all SNPs are perfectly correlated this
would become a burden test, but also allows SNPs in the
same region to have effects in opposite directions. Significance is assessed by region rather than by SNP. We considered each gene that harbors a variant in the WSCR as a
separate region for a total of 26 regions. To test for an overall
effect of variants in the ASD genes we collapsed the 61 autosomal genes into one region. We used the beta function
shape parameters (1,50) to put more weight on SNPs that
have lower minor allele frequency, reasoning that rare causal
alleles potentially have a greater effect size. We again controlled for age, sex, and the first four principal components.

2.7.3

| Polygenic risk score

Polygenic Risk Scores (PRS) can be used to test if there is
a contribution of many loci of small effect on the phenotype of interest by summing the effects of variants that
may have not reached genome‐wide significance. For a discovery set, we used the publically available summary
statistics from the most recent Psychiatric Genome Consortium genome‐wide association study (GWAS) of autism
spectrum disorder (The Autism Spectrum Disorders Working Group of the Psychiatric Genomics Consortium 2017),
reasoning that genetic risk for autism would contribute to
SRS scores. The best‐fit PRS was determined using the
high‐resolution functionality in the PRSice software (Euesden, Lewis, & O'Reilly, 2015). All the variants identified
throughout the exome with a MAF >0.05 and that are also
present the in the discovery set were used to calculate the
PRS. Sex, age, and the first four PCs were included as
covariates. After clumping there were a total of 23,191
variants used to calculate the PRS. PRSice was used to calculate the significance of the PRS at the best‐fit p‐value
threshold using 10000 permutation to determine an empirical p‐value. PRS for each of the samples was calculated
for the total SRS T‐score as well as the subscores.

2.8
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| Other statistical analyses

All remaining statistical tests were done in the R v3.1.3
environment. Two sample t‐tests were used to compare the
means of two groups. ANOVA was used to test differences
in mean of subscales of SRS. TukeyHSD post hoc comparison was performed using the multcomp package. The
qqman (Turner, 2014) package was used to generate manhattan and qq plots.

3
3.1

753

| RESULTS
| SRS variability in Williams syndrome

The unique social profile of Williams syndrome includes
increased social motivation (e.g., indiscriminate approach
to strangers), strong eye contact, use of affective language,
emotional sensitivity as well as poor social judgment and
restricted interests (Doyle et al., 2004; Gosch & Pankau,
1997; Klein‐Tasman & Mervis, 2003; Klein‐Tasman et al.,
2007; Reilly et al., 1990; Tager‐Flusberg & Sullivan,
2000). Many comorbidities, such as specific phobias,
ADHD, and anxiety, have been commonly reported in WS
as well (Dykens, 2003; Einfeld, Tonge, & Florio, 1997;
Einfeld, Tonge, & Rees, 2001; Leyfer, Woodruff‐Borden,
Klein‐Tasman, Fricke, & Mervis, 2006; Switaj, 2001). To
quantify social features in our WS cohort, we used a standard instrument for assessing social reciprocity, parent‐
reported SRS scores from 85 individuals with WS.
We examined the SRS and its subscores in depth. In
our sample, the SRS T‐scores are continuously distributed
in the WS population with a male mean T‐score ± SD of
64.58 ± 12.28 (mean male raw score ± SD 74.53 ± 32.03)
and female mean T‐score ± SD of 62.94 ± 11.04 (mean
female raw score ± SD 67.08 ± 26.04) (Figure 1). There is
no significant difference in SRS T‐scores (t70.76 = 0.6365,
p = 0.52) or raw scores (t65.907 = 1.1445, p = 0.257)
between sexes. To benchmark the WS values, Constantino
& Todd, 2003 measured raw SRS scores in 788 twin pairs
from the general population ranging in ages between 7 and
15 and estimated the mean male raw score ± SD as
35.3 ± 22.0 and the female mean raw score ± SD as
27.5 ± 18.4; males and females were significantly different. In our analysis, we show that individuals with WS
have SRS scores that are shifted toward the more impaired
end of the spectrum, and we do not detect any significant
sex differences in WS, which has been observed in the
general population.
Our results largely replicate the results seen in Klein‐
Tasman et al., 2010;. The overall T‐score distribution
reveals that 40% of our samples fall into the no clinically
significant impairment range, followed by 41.1% with mild
to moderate deficits, and 18.9% with severe deficits. The
number of individuals showing no clinical signs in our
sample is higher than the 13.4% observed when the parents
completed the SRS in Klein‐Tasman et al., 2010; but more
similar to the teacher reported results of 38.8%. The subscores also follow a similar pattern to what has been
reported previously (Klein‐Tasman et al., 2010). There is a
significant effect of subscale on the T‐scores
(F4,420 = 24.759, p < 0.001) (Figure 1b). Post hoc Tukey
all‐pairwise comparisons show that social motivation has
significantly better T‐scores than all other subscales,
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F I G U R E 1 Distribution of Social Responsiveness in 85 individuals with typical WS deletion. (a) Distribution of the raw SRS scores. (b)
Severity bins of SRS and subcategory scores

consistent with Klein‐Tasman et al., 2010. The social
awareness and communication scales are not different from
each other, but both show less impairment than social cognition and restricted and repetitive behaviors. Social cognition and restricted and repetitive behaviors were
significantly more impaired than all other subscales, but
not each other.
The distribution of SRS scores in WS points to the possibility of additional genetic variants that modify the social
phenotype. First, we see a larger standard deviation in the
SRS data in our sample compared to that of the norming
population from Constantino & Todd, 2003. The extra variance suggests individuals with WS are more sensitive to
genetic or environmental factors that modify social behavior. Second, in our sample there are only two individuals
that show severe social motivation deficits, and these individuals also show severe deficits in the total SRS T‐score
as well as all other subscales. These outliers also suggest
some individuals may harbor additional rare variants of
large effect size resulting in a phenotype that is more
frankly autistic. To test these two hypotheses, we generated
and analyzed exome sequences from this cohort of WS
patients.

3.2 | Identification of variants in the
Williams syndrome critical region
Williams syndrome individuals are hemizygous for 1.5–
1.8 Mbp on chromosome 7q11.23. Since they only have

one remaining allele, our primary hypothesis was that second hits in genes believed to impact social phenotypes
within the WSCR would produce more extreme social phenotypes. We performed whole exome sequencing on 85
individuals, all whom have an SRS score. We called 120
variants in the remaining WSCR and annotated them with
the allele frequency in our sample, ExAC allele frequency,
mutation consequence, clinical significance as assessed by
ClinVar, and scores that assess deleteriousness of missense
variants cataloged in dbNSFP. (Supporting Information
Table S1). Table 1 shows the 55 exonic variants discovered
in the region. For display purposes we have only included
the CADD PHRED score and the MetaLR score, which is
a composite score that incorporates information from nine
other measures of deleteriousness and has been shown to
have more predictive power than the individual component
scores (Dong et al., 2015).
We first examined this set of variants to determine if
any loss‐of‐function variants might be present in individuals with particularly severe SRS scores in our sample.
Upon inspection of the exonic variants, we notice no severe likely protein‐truncating variants. As homozygous nulls
for at least two genes in this region (ELN and GTF2I) are
expected to be lethal (Li et al., 1998; Sakurai et al., 2011),
we also assessed missense mutations in these genes that
might alter function. Based upon the predictions of
MetaLR all the missense mutations called are expected to
be tolerated. None of the variants were reported as pathogenic in ClinVar. The highest CADD scores observed are a
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novel variant and SNP rs35607697, both located in the
TBL2 gene. Another novel variant was identified as a synonymous change in the BAZ1B gene. Similar results are
found for nonexonic variants in the region (Supporting
Information Table S1). This suggests that beyond the
reduced copy number of the entire WSCR, neither a second
rare deleterious coding variant nor any common missense
mutations in the WSCR explain individuals with outlier
SRS scores. It should be noted that we did not identify any
variants in GTF2I, one of the primary candidates for mediating the social‐cognitive profile.

3.3

| Association analyses

To test the hypothesis that individual variants in the WSCR
can explain the variance in the SRS scores in our sample,
we perform classic quantitative trait loci associations. Rare
disease populations by definition will have small sample
sizes such as in this study. We calculated the power of our
study to be able to detect variants with different effect sizes
and also calculated the number of samples that would be
needed to reach a certain power given an effect size (Figure 2). We calculated the power for analyzing variants in
the WSCR, variants in 71 ASD genes, and the remaining
variants identified throughout the exome. Since we are conducting fewer tests in the WSCR, we have the most power
in this analysis, however we are still only powered to
detect very large effect sizes that might be unmasked by
the hemizygosity of the region, such variants would need
to explain more than 10% of the heritability of the trait to
achieve 80% power. Most effect sizes for common variants
in diploid regions of the genome typically assessed by
GWAS for complex traits explain around 1% of the heritability of the trait (Manolio et al., 2009). In order to be
able to detect variants that explain 5% of the variance of
the trait with 80% power using only variants in the WSCR
would require 312 individuals (Figure 2b).
We then performed a quantitative trait association analysis of common variants in the WSCR on the SRS T‐scores
from the whole cohort. We used PLINK to test for an association on each of the 34 common variants in the WSCR,
defined as MAF > 0.05, which corresponds to an allele
count of at least four in the WSCR due to the hemizygosity
of the region. We adjusted for age, sex, and ancestry. We
found no association between any SNP and SRS that survived multiple comparison corrections (Figure 3a). The top
five SNPs are displayed in Table 2. Interestingly, the most
significant SNP, rs2074754, is located in the BAZ1B gene,
which has been previously implicated in contributing to the
cognitive phenotypes in WS (Lalli et al., 2016). Furthermore, the next most nominally significant SNP is
rs61438591, an intronic variant in the GTIF2RD1 gene,
another gene highly implicated in the cognitive and social
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phenotypes seen in WS (van Hagen et al., 2007; Howard et
al., 2012; Schneider et al., 2012; Young et al., 2008).
As the common variants in WSCR showed no association, we wanted to test for the possibility that rare variants
could contribute to the variability in SRS T‐scores. To test
this, we used SKAT‐O, which tests all variants in the
region at once and weights each variant by its minor allele
frequency. Similarly, we included age, sex, and ancestry as
covariates. We tested each gene in the WSCR independently, because we hypothesized only certain genes in the
region, such as STX1A, LIMK1, CYLN2, BAZ1B,
GTF2IRD1 (Dai et al., 2009; Fujiwara et al., 2016; Gao et
al., 2010; van Hagen et al., 2007; Hoogenraad et al., 2002;
Lalli et al., 2016; Meng et al., 2002; Morris et al., 2003;
Sakurai et al., 2011) that have been implicated in the cognitive phenotypes would contribute to the social phenotype
rather than the entire region. While no gene p‐value survives multiple testing corrections, the ELN gene has the
most nominally significant p‐value of 0.013.
The results of our analysis of variation in the WSCR
suggest that common and rare variants in the remaining
allele do not strongly influence social behavior in WS. This
does not exclude the possibility that a second deleterious
hit or common variation in other genes outside the region
contributes to the variation in the SRS T‐scores. To test
this, we next examined variation in 71 genes known to be
associated with autism spectrum disorders (Sanders et al.,
2015). These genes should be enriched for loci that affect
social behavior and genetic variation in these genes could
contribute to variability seen in WS. We called 1,367 variants in the 71 genes (Supporting Information Table S2).
We annotated the variants as above, with clinical significance and measures of deleteriousness compiled in
dbNSFP. There are 313 (22.9%) variants that had at least
one submission to ClinVar. None of these variants had previous evidence to support pathogenicity. There are 33 missense variants predicted to be deleterious by MetaLR that
are seen in 36 individuals in our sample. Despite having a
putatively deleterious variant the distribution of SRS T‐
scores is similar between individuals either carrying or
lacking
deleterious
variants
in
these
genes
(t82.999 = 0.6878, p‐value = 0.4935). There are seven variants that should result in a truncated protein, one stop gain
in the USP45 gene and six frameshift mutations. Only one
sample harboring one of these mutations has a severe SRS
T‐score of 77. All these protein‐truncating mutations are
also observed in the ExAC cohort.
We next tested for associations of each of the 381 common variants (MAF >0.05) in these genes. No SNP was
significant after multiple testing corrections (Figure 3b).
The top five SNPs are located in Table 2. Since each of
these genes has been associated with ASD, we hypothesized that rare and common variants in each of the genes
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T A B L E 1 Annotation of 55 exonic variants discovered in the WSCR
CADD
PHRED

Chr

Start

avsnp147a

Alt

MAF

Transcript

Gene

Consequence

MetaLR
score

MetaLR
predictionb

7

72413057

rs782618986

A

0.005882

NM_172020

POM121

p.S577N

0.011

T

0.006

7

72717686

rs145622470

T

0.01176

NM_001168347

NSUN5

p.P399P

.

.

8.726

7

72719048

rs34913552

A

0.01176

NM_001168347

NSUN5

p.P183S

0

T

0.002

7

72738534

rs371073794

T

0.01176

NM_001281450

TRIM50

p.P84P

.

.

15.11

7

72738561

rs61741334

T

0.04706

NM_001281450

TRIM50

p.I75I

.

.

11.01

7

72738762

rs6980258

T

0.9882

NM_001281450

TRIM50

p.L8L

.

.

0.46

7

72738763

rs6980124

G

0.9882

NM_001281450

TRIM50

p.L8P

.

.

7

72744246

rs200493820

T

0.01176

NM_001281304

FKBP6

p.T90M

0.492

T

7

72754645

rs56301507

A

0.01176

NM_001281304

FKBP6

p.L168L

.

.

7

72856676

rs1178978

T

0.01176

NM_032408

BAZ1B

p.Q1434Q

.

.

11.69

7

72857130

rs150115317

T

0.01176

NM_032408

BAZ1B

p.R1340K

0.025

T

23.6

7

72891754

rs2074754

T

0.4

NM_032408

BAZ1B

p.S679S

.

.

10.13

7

72936183

.

A

0.01176

NM_032408

BAZ1B

p.H27H

.

.

7

72951640

rs142166738

G

0.01176

NM_001197244

BCL7B

p.A142A

.

.

7

72985148

rs35607697

T

0.03529

NM_012453

TBL2

p.V345I

0.014

T

26.3

7

72987758

.

C

0.01176

NM_012453

TBL2

p.F164V

0.154

T

27.3

7

72992858

rs76029572

G

0.07059

NM_012453

TBL2

p.E8Q

0.054

T

9.196

7

73010754

rs61738649

T

0.05882

NM_032951

MLXIPL

p.L626L

.

.

2.706

7

73013901

rs13235543

T

0.1294

NM_032951

MLXIPL

p.P342P

.

.

6.53

7

73020301

rs799157

C

0.9647

NM_032951

MLXIPL

p.S253S

.

.

2.151

7

73020337

rs3812316

G

0.1059

NM_032951

MLXIPL

p.Q241H

0.001

T

19.07

7

73020439

rs12539160

T

0.01176

NM_032951

MLXIPL

p.A207A

.

.

12.68

7

73083889

rs61743139

T

0.02353

NM_001077621

VPS37D

p.A93A

.

.

18.4

7

73097082

rs79849491

G

0.02353

NM_032317

DNAJC30

p.F224F

.

.

0.66

7

73097238

rs1569062

A

0.3294

NM_032317

DNAJC30

p.Y172Y

.

.

11.69

7

73122977

rs2229854

A

0.05882

NM_001165903

STX1A

p.N50N

.

.

11.25

7

73150934

rs138932141

A

0.01176

NM_001145364

ABHD11

p.D244D

.

.

7

73245591

rs142910620

T

0.01176

NM_001305

CLDN4

p.A20A

.

.

7

73254812

rs13241921

C

0.7882

NM_152559

WBSCR27

p.Q107R

0

T

7

73275565

rs11770052

A

0.7647

NM_182504

WBSCR28

p.I14N

0

T

15.45

7

73279361

rs61742124

T

0.1294

NM_182504

WBSCR28

p.L37L

.

.

14.82

7

73279413

rs118088869

T

0.03529

NM_182504

WBSCR28

p.R55W

0.01

T

15.49

7

73280020

rs1136647

T

0.7176

NM_182504

WBSCR28

p.T205T

.

.

12.3

7

73466285

rs6979788

G

0.01176

NM_001278913

ELN

p.A271A

.

.

0.001
13.74
3.802

2.032
7.437

1.115
17.87
0.001

1.511

7

73470714

rs2071307

A

0.4706

NM_001278913

ELN

p.G412S

0

T

6.674

7

73474268

rs200512332

T

0.01176

NM_001278913

ELN

p.V408V

.

.

9.149

7

73474367

rs61734584

A

0.01176

NM_001278913

ELN

p.G441G

.

.

1.008

7

73474825

rs17855988

C

0.07059

NM_001278913

ELN

p.G500R

0.007

T

23.2

7

73477524

rs140425210

A

0.01176

NM_001278913

ELN

p.G529S

0.131

T

23.7

7

73631177

rs144269935

G

0.02353

NM_014146

LAT2

p.I39M

0.013

T

25.9

7

73651743

rs3135688

C

0.01176

NM_001278792

RFC2

p.V160V

.

.

8.01

7

73663362

rs1805395

C

0.05882

NM_001278791

RFC2

p.E3E

.

.

7.454
(Continues)
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T A B L E 1 (Continued)
Chr

Start

avsnp147a

Alt

MAF

Transcript

Gene

Consequence

MetaLR
score

MetaLR
predictionb

CADD
PHRED
18.78

7

73731906

rs148561130

T

0.02353

NM_003388

CLIP2

p.P10P

.

.

7

73811479

rs76865959

C

0.01176

NM_003388

CLIP2

p.R897R

.

.

7

73814702

rs17145468

A

0.03529

NM_003388

CLIP2

p.D926E

0.006

T

17.3

7

73814749

rs2522943

C

0.9647

NM_003388

CLIP2

p.R942P

0

T

18.33

7

73929826

rs111256098

T

0.01176

NM_001199207

GTF2IRD1

p.G139G

.

.

12.93

7

73932488

rs112098981

G

0.01176

NM_001199207

GTF2IRD1

p.A179A

.

.

7

73932494

rs145535993

T

0.02353

NM_001199207

GTF2IRD1

p.V181V

.

.

7

73932560

rs17851629

G

0.2118

NM_001199207

GTF2IRD1

p.E203E

.

.

7

73933793

rs148463467

T

0.01176

NM_001199207

GTF2IRD1

p.V252V

.

.

14.93

7

73944095

rs61744518

T

0.02353

NM_001199207

GTF2IRD1

p.P406P

.

.

16.53

7

73944185

rs2240357

C

0.2353

NM_001199207

GTF2IRD1

p.Y436Y

.

.

7

73953017

rs55634982

T

0.01176

NM_001199207

GTF2IRD1

p.S517S

.

.

7

74211576

rs587728502

C

0.01176

NM_173537

GTF2IRD2

p.M759V

0.021

T

4.969

9.272
10.27
9.058

0.434
14.02
0.893

Notes. “.” Refers to information that is not applicable; “T” the missense mutation is predicted to be Tolerated.
a

b

1.0

b
300

effect sizes

0.0
0.0

0.1
0.2
0.3
0.4
0.5
heritability explained by QTL

200
100

WSCR
ASD
WEX

0.5
0.4
0.3
0.2
0.1
0.05

0

Sample size

0.6
0.4
0.2

Power

0.8

a

0.0

0.2

0.4
Power

0.6

0.8

F I G U R E 2 Power analysis. (a) The power to detect variants of different effect sizes for this study. The alpha for the three different sets of
analyses was determined by using the Bonferroni correction based on the number of SNPs tested in each analysis. (WSCR: variants in the
WSCR, ASD: variants in the 71 ASD genes, WEX: all remaining variants exome wide). (b) The predicted sample sizes that would be required to
achieve different levels of power for detecting variants of different effect sizes. The sample size predictions were only done using the alpha for
the number of SNPs tested in the WSCR. The horizontal dashed line indicates the sample size of this study

could contribute to SRS. We performed SKAT‐O on the
variants located in the autosomal ASD genes altogether,
which also showed that there is little evidence to support
variants in these 68 ASD genes have a strong effect on
SRS T‐scores, p = 0.431.
While it would be underpowered for any but the largest
effect sizes (Figure 2a), for thoroughness we did an unbiased scan of the whole exome. We also examined the polygenic contribution of common variants to the SRS. The
common variant analysis was performed on 66,620 variants
(Figure 3c). The most nominally significant single SNP is
rs527221 located in the DMPK gene, which is responsible

for causing type 1 myotonic dystrophy (Brook et al., 1992)
(Table 2). While there is suggestive evidence for single
variants such as rs527221, we calculated the polygenic risk
scores (PRS) for each of the individuals in our sample to
test if exome wide there are many SNPs of small effect
that contribute to the social phenotype in WS. We used the
summary statistics from the most recent PGC GWAS on
autism spectrum disorders to calculate the PRS for our
sample (The Autism Spectrum Disorders Working Group
of the Psychiatric Genomics Consortium 2017). We reasoned the polygenic risk of autism would be correlated
with the SRS because this is a questionnaire used to assess
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10

0.8
0.6
0.4
0.2

1.0

1.5

− log10(p )

2.0

8
6

60

4

40

rs2074754
2

20

0.5

0

0
NSUN5

BCL7B

TRIM50

0.0

STX1A

TBL2

FKBP6

ELN

ABHD11

MLXIPL

FZD9

EIF4H

GTF2I
GTF2IRD1

MIR590

NCF1
LOC101926943

LAT2

DNAJC30

0.5
1.0
1.5
Expected − log10(p )

CLIP2

LIMK1

CLDN4

VPS37D

BAZ1B

0.0

80

Recombination rate (cM/Mb)

Observed − log10(p )

100

r2

a

GTF2IRD2

RFC2

WBSCR22
MIR4284
LINC00035
CLDN3
WBSCR27

73

1.5

2.0

73.5
Position on chr7 (Mb)

74

0.5

1.0

− log10(p )

1.5
1.0
0.5

0.0

Observed − log10(p )

b

0.0

0.0

1.0
2.0
Expected − log10(p )

1 2

3 4

6

7

9

12 15

20

23

Chromosome

c

4
3
2

1

2

3

− log10(p )

4

5

1
0

Observed − log10(p )

5

6

0
0

1
2
3
4
Expected − log10(p )

5

1

2

3 4

6

8

10 12

15

19 23

Chromosome

F I G U R E 3 Variants in the WSCR, ASD genes, or whole exome do not contribute to SRS variability in a sample of WS with typical
deletions. (a) qq plot showing distribution of p‐values for common variants in the WSCR. Locus zoom plot showing the SNPs tested in the
WSCR, highlighting the most nominally significant SNP in BAZ1B. (b) qq and manhattan plot for variants called in 71 genes associate with
ASD from Sanders et al. (2015). (c) qq and manhattan plot for variants exome wide. Blue line demarcates a suggestive p value threshold of
1 × 10−5
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T A B L E 2 Top five SNPs from quantitative trait locus associations
SNP

Alt
allele

MAF

Transcripta

Gene

Consequence

Beta

95% Confidence
interval

Raw
p‐value

FDR

Analysis
groupb

rs2074754

T

0.4

NM_032408

BAZ1B

p.S679S

3.429

0.9415 –5.917

0.0085

0.2899

WSCR

rs61438591

C

0.2

.

GTF2IRD1

Intronic

3.506

0.4648–6.547

0.0267

0.4542

WSCR

rs17851629

G

0.22

NM_016328

GTF2IRD1

p.E171E

2.932

−0.0839 to 5.948

0.0605

0.6851

WSCR

3.402

−0.7692 to 7.572

0.1141

0.8466

WSCR

−3.735

−8.587 to 1.117

0.1367

0.8466

WSCR

1.96–16.58

0.0151

0.6587

ASD

1.567–13.58

rs3812316

G

0.11

NM_032951

MLXIPL

p.Q241H

rs76029572

G

0.07

NM_012453

TBL2

p.E8Q

rs12983010

G

0.07

NM_14469

CAPN12

p.C287R

9.286

rs12553775

A

0.11

.

PHF2

Intronic

7.573

0.0157

0.6587

ASD

rs140682

C

0.48

NM_000810

GABRA5

p.V202V

−4.377

−7.874 to 0.8801

0.0164

0.6587

ASD

rs1805482

A

0.35

NM_000834

GRIN2B

p.S555S

4.918

0.9301–8.906

0.0180

0.6587

ASD

rs112318565

G

0.06

.

ARID1B

Intronic

10.22

1.918–18.51

0.0182

0.6587

ASD

0.1522

WEX

0.1522

WEX

0.1522

WEX

0.1522

WEX

0.1522

WEX

rs527221

C

0.11

NM_001288765

DMPK

p.L334V

13.78

rs2546028

C

0.54

.

ZNF792

UTR5

−6.95

rs2546029

G

0.54

.

ZNF792

−6.95

UTR5

8.246–19.31

5.70 × 10

−6

−9.801 to −4.099

8.32 × 10−6

−9.801 to −4.099

−6

8.32 × 10

−6

rs1811

G

0.46

NM_001099437

ZNF30

p.Q124R

7.166

4.116–10.22

1.60 × 10

rs2651109

C

0.46

NM_001099437

ZNF30

p.S215S

7.166

4.116–10.22

1.60 × 10−6

Notes. a“.” Refers to information that is not applicable; bWSCR (Williams syndrome critical Region), ASD (71 genes associated with ASD), WEX (variants across
Whole Exome).

behaviors that are affected by autism. Variants from the
PGC GWAS were included if the p‐value for the variant
was under the threshold determined by the high‐resolution
screen in the PRSice software (Euesden et al., 2015). Interestingly, only the PRS for the motivation subscore was
nominally significant (p = 0.033), but after permutation to
determine an empirical p‐value it was not significant
(p = 0.308). The correlations of the PRS for each of the
samples and the subscore as well as total SRS are shown
in Supporting Information Fig. S1. Counterintuitively, there
is a negative correlation between the PRS and motivation
subscore. While this is the largest correlation between the
PGS and subscores it implies that more genetic risk for autism leads to a lower and less impaired social motivation T‐
score. However, given the small sample size and small
number of SNPs available from whole‐exome sequencing
compared to whole‐genome genotyping we are wary of
making strong conclusions from this analysis.
We and others (Klein‐Tasman et al., 2010) have shown
that individual subscores of the SRS are affected differently
by the deletion of the WSCR. Therefore, we wanted to rule
out the possibility that variants are indeed affecting specific
subscales of social behavior, but that testing the total SRS
score is masking those effects. Thus, in an exploratory
manner, we repeated the quantitative trait loci associations
for each of the subscores of the SRS using the variants in
the WSCR, 71 ASD genes, and the remaining whole
exome variants. Since the sample size is small we conducted these associations for exploratory and hypothesis

generating purposes. The top five SNPs from each association are reported in Supporting Information Tables S3–S5.
For each of the analyses we see similar variants showing
the highest association as were associated with the total
SRS, likely due to the high correlation between the SRS
and the subscores (Supporting Information Fig. S2). Thus,
an analysis of the total SRS was not masking independent
genetic effects on each subscale.

4

| DISCUSSION

Phenotypic variability has been appreciated in many of the
symptom domains of WS including the cardiovascular phenotypes, the unique cognitive profile, and in social behavior (Anney et al., 2012; Joyce, Zorich, Pike, Barber, &
Dennis, 1996; Porter & Coltheart, 2005). Here, we have
described the variability of reciprocal social behavior in a
sample of 85 individuals with the typical WS deletion
using the SRS‐2. Our results replicate the findings of
Klein‐Tasman et al., 2010, revealing that overall individuals with WS have SRS scores that are shifted to the more
socially impaired end of the distribution, with most problems relating to the social cognition and restricted and
repetitive behavior subscales of the SRS while social motivation is spared.
We also note that sex differences in the general population have been reported previously in the literature for
SRS. These sex differences were not consistent with
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different genetic factors contributing to the SRS in boy
and girls, but due to discrepant effects of common genetic
and environmental factors on SRS, such as differences in
sensitivity to environmental factors or the X‐inactivation
phenomenon (Constantino & Todd, 2003). However, we
do not see evidence of sex effects in our sample of individuals with WS. The magnitude of the difference
between males and females in our sample is similar to
what was reported in the general population, so our lack
of a significant finding could be due to our small sample
size. The standard deviation of the SRS is large in both
the general population and still larger in the WS population, so it may also be that larger sample sizes are needed
to overcome the considerable variance in the data. The
fact that the WS population has a larger standard deviation could also suggest that individuals with the deletion
are sensitized to other factors that contribute to variation
in the SRS such as background genetic variation or environmental factors.
We performed whole‐exome sequencing on our sample
of 85 individuals to test for additional genetic contributions
to the variability seen in social behavior in individuals with
WS. We used the identified variants to test the hypothesis
that genetic variation in the remaining WSCR allele can
explain some of the variability in SRS T‐scores. Genes in
this region have a dosage sensitive effect on social behavior evidenced from the contrasting social phenotypes of the
WS deletion and the reciprocal duplication, suggesting that
variants in the remaining WSCR allele that affect expression or function of the genes could further contribute to the
social phenotype (Merla et al., 2010). We called 120 variants in the WSCR with 55 variants being exonic. We used
evidence such as the amino acid change, clinical significance suggested by the ClinVar database, and multiple
algorithms to predict the consequences of the variants.
Within the WSCR we do not find any variants that cause
protein truncation. None of the missense variants are predicted to be deleterious based on the MetaLR composite
score. Of the nine variants that have been submitted to
ClinVar, all were described as benign or likely benign. A
quantitative trait association analysis using the common
variants in the region resulted in no SNP that survived
multiple testing corrections. The most significant SNP,
rs2074754, is a synonymous SNP in the BAZ1B gene. This
gene encodes for a protein product in the bromodomain
protein family that modifies chromatin to affect transcription and has been implicated in the cognitive phenotypes in
WS. Knocking down this gene in human derived induced
pluripotent stem cells upregulates genes involved in mitosis
as well as downregulating genes that are involved in the
development of the nervous system (Lalli et al., 2016) The
second most nominally significant SNP, rs61438591, is an
intronic variant in GTF2IRD1, which encodes for a

KOPP

ET AL.

transcription factor that has been suggested to contribute to
the cognitive and social behavior deficits (Dai et al., 2009;
Howard et al., 2012; Schneider et al., 2012; Tassabehji et
al., 2005; Young et al., 2008). If future studies with
increased power replicate this association, it would suggest
that noncoding variation, perhaps controlling the expression
of this gene, might contribute to variation is social behavior. We also tested the association of all variants in the
WSCR using SKAT‐O. This test indicated no variants with
sufficient effect size were detected in the WSCR.
While we have not shown evidence that variants in the
remaining WSCR contribute to the social phenotype in
WS, we cannot conclusively discard this hypothesis. However, our study does clearly indicate that the alleles genotyped here are either not causative or exert too small an
effect size on SRS for our current power (Figure 2), but it
does not rule out variants of small effect on social behavior
in the region. Research on other copy number variants
associated with ASDs showed that larger CNVs tended to
have genes of smaller individual effect size and suggests
the phenotype of the overall CNV is due to the cumulative
effect of each of those genes (Sanders et al., 2015). Further
we did not detect any variants in the gene GTF2I, which
has been highly suspected of contributing to the social
behaviors in WS (Borralleras, Sahun, Pérez‐Jurado, &
Campuzano, 2015; Crespi & Hurd, 2014; Dai et al., 2009;
Morris et al., 2003; Sakurai et al., 2011). The lack of variant calls in our sample could be due to the fact that GTF2I
is under stringent purifying selection. Indeed, looking at
the ExAC data covering this gene, they show that there are
fewer missense variants than expected by chance. ExAC
discovered 62 synonymous and 56 missense mutations in
60,706 people (Lek et al., 2016). In our sample of 85 individuals we would expect to see variants in ExAC that have
an allele frequency of >0.0059, which is an allele count of
one in our sample. There are ten variants with an allele frequency >0.0059 detected in ExAC, only three of which are
exonic. Thus, we would need a much larger sample size to
investigate coding variants in GTF2I. The two linked variants in GTF2I that have previously been associated with
oxytocin responsiveness and amygdala reactivity,
rs1322743 and rs4717907, are intronic and were not covered in our sequencing (Procyshyn et al., 2017; Swartz et
al., 2017).
We further used the genetic data to investigate the role
of variation in 71 genes that have been associated with
ASD. WS and ASD do show phenotypic overlap (Crespi &
Procyshyn, 2017; Klein‐Tasman et al., 2009), and we reasoned that these genes should be enriched for functional
roles in social behaviors. Likewise, the presence of outlier
scores on the SRS that indicated severe impairment, suggested there could be possible second deleterious hits on
top of the WS deletion in our dataset. Second hits are
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expected to be rare but have been observed in WS to
explain a case of a child with comorbid seizures (Popp et
al., 2016). Inspecting the 1,367 variants discovered in the
ASD genes, 313 variants have been previously submitted
to ClinVar, none of which show evidence for any
pathogenicity. We observed seven protein‐truncating mutations that do not associate with severe SRS T‐scores. Several missense mutations were predicted to be deleterious,
but there was no association between individuals that had a
putative deleterious variant and a more impaired SRS
score. Testing the common and rare variants in these genes
showed no associations with the social phenotype. Similar
results were found when we performed the association
analyses on all the variants discovered in the cohort. The
most significant SNP was rs527221, a nonsynonymous
variant in the DMPK gene, which is responsible for causing type 1 myotonic dystrophy, severe childhood forms of
which have been associated with ASD (Ekström, Hakenäs‐
Plate, Samuelsson, Tulinius, & Wentz, 2008). We also
tested if polygenic risk for increased ASD liability is associated with the SRS T‐score and subscores. This boosts our
ability to detect the impact of many loci with small effects.
The largest correlation was between the PRS and the social
motivation subscore, although this was not significant.
WS seems to affect specific domains of social behavior
as evidenced by significant differences between the subscores of the SRS. This observation led us to an exploratory examination of associations with the subscores of the
SRS and test if different genetic variants contribute to each
subscore. Overall using variants from the WSCR, ASD
genes, or the whole exome identified the same variants as
nominally significant. The SRS and the subscores are very
correlated, but the social motivation in the WS sample is
the least correlated with all other scores. This reflects that
fact that social motivation tends to be rated within the normal range in WS, while the other scores are often higher.
Interestingly, the whole exome association on the motivation T score leads to the lowest FDR values compared to
the other scores, suggesting that there may be more genetic
signal when using this subscale. Indeed, this decoupling of
the social motivation subscale from other SRS items highlights the possibility that the social motivation subscale
might provide useful clinical information going forward;
individuals carrying the WSCR deletion yet not showing a
spared social motivation might warrant a deeper examination for additional factors impacting their presentation.
There are several limitations to our study that should
be addressed in future research. First this study genotyped
and assessed only the probands and not their parents.
Having genetic information from trios would allow us to
distinguish between variants that are inherited or de novo,
which would aid in interpretation and prioritization of
variants. Furthermore, being able to compare the SRS
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score of the individual with WS to biparental SRS mean
would let us control for effects of background genetic
variation (Moreno‐De‐Luca et al., 2015). Second, we are
limited to investigating exonic variation. While interpretation of exonic variants is more straightforward because
they potentially disrupt coding sequences, and can aid in
the detection of deleterious rare variants, we could be
missing important regulatory information that is located in
promoters or introns of genes. Third, we were not able to
control for intellectual functioning of the individuals with
WS. The SRS has been reported to not correlate with
intellectual functioning (Constantino et al., 2003), but
Klein‐Tasman et al., 2010 found significant negative correlations between intellectual functioning and the total
SRS T‐score when parents completed the report, but not
when teachers completed the report. SRS values have
been shown to be dependent on levels of expressive language, nonverbal IQ, and behavioral problems. A subset
of SRS questions was selected to ameliorate these dependences (Sturm, Kuhfeld, Kasari, & McCracken, 2017).
The short form of the SRS as well as other questionnaires
that assess adaptive skills and social behaviors could be
used in the future to provide supporting information about
the social phenotype and underlying genetics in WS.
Finally, while our study represents the largest single collection of WS samples reported to date, it is only powered to detect strong effects of common variants due to
our small sample size. This is challenging to overcome
due to the low prevalence of WS.
In conclusion, we have tested the hypothesis that variation in the remaining WSCR allele affects the social phenotype of individuals with WS, by applying whole exome
sequencing to a sample of 85 individuals with typical WS
deletions. We show that common and rare variants in the
region do not associate with SRS T‐scores in our sample.
Furthermore, we show that variation outside of the region
does not account for the social variability. This is not to
say that genetic variation does not play a significant role in
phenotypic variability in WS, but that it will require larger
sample size to detect. In the future, applying whole genome
sequencing to a sample of individuals with WS might elucidate the roles of genetic variation in the regulatory elements. Whole genome data could also allow for more
accurate breakpoint determination. Redundant sequences in
the low copy number repeat areas at either end of the WS
deletion prevent accurate end point detection by CMA.
This will be an interesting avenue to pursue in order to
investigate how deletion size variation among individuals
with typical 1.5 to 1.8 MB deletions contributes to social
behavior. For example, Porter et al. showed that those with
larger (1.8 Mb deletions) had decreased executive functions
(Porter et al., 2012). It is also worth noting that the current
genetic data set has additional clinical data available, which
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can be queried in the future for the presence of more substantial associations with other WS‐related phenotypes.
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